Clinical Trials Logo

Neoplasm Metastasis clinical trials

View clinical trials related to Neoplasm Metastasis.

Filter by:

NCT ID: NCT01767935 Terminated - Pain Clinical Trials

Cryosurgery and Radiation Therapy in Treating Patients With Painful Bone Metastases

Start date: July 2014
Phase: N/A
Study type: Interventional

This pilot clinical trial studies cryosurgery and radiation therapy in treating patients with painful bone metastases. Cryosurgery kills tumor cells by freezing them. Radiation therapy uses high-energy x-rays and other types of radiation to kill tumor cells and shrink tumors. Giving cryosurgery together with radiation therapy may kill more tumor cells

NCT ID: NCT01765907 Completed - Bone Metastasis Clinical Trials

Antalgic Treatment of Painful Bone Metastases by US-guided High Intensity Focused Ultrasound (HIFU)

Start date: December 2012
Phase: Phase 1
Study type: Interventional

Antalgic treatment of painful bone metastases by US-guided High Intensity Focused Ultrasound (HIFU).

NCT ID: NCT01763970 Completed - Sarcoma Clinical Trials

Stereotactic Radiation Therapy for Pediatric Sarcomas

Start date: November 2013
Phase: N/A
Study type: Interventional

The stereotactic body radiation therapy (SBRT) literature focuses on clinical outcomes in the adult population. However, SBRT has a particularly strong rationale for application in pediatrics given that high biologically effective doses have been shown to increase control in histologies, such as sarcoma, which are common in the pediatrics population. With stereotactic radiation therapy techniques, a reduction in normal tissue dose surrounding the target lesion of interest may also be accomplished resulting in lower toxicity. Given that pediatric patients with sarcomas, presenting with limited metastases in lung and bone, are still considered to be a curable population with aggressive local therapy, SBRT could have a significant impact on outcomes in oligometastatic patients who may be otherwise unresectable.

NCT ID: NCT01763450 Active, not recruiting - Colorectal Cancer Clinical Trials

Bevacizumab Therapy Untreated Unresectable Liver Metastases From Colorectal Cancer

Start date: September 2012
Phase: Phase 2
Study type: Interventional

A multi-center, non-random, open study ,to observe efficacy and safety of bevacizumab plus Oxaliplatin based multidrug chemotherapy as conversion therapy for patients with previously untreated unresectable liver metastases from colorectal cancer.

NCT ID: NCT01763385 Recruiting - Brain Metastases Clinical Trials

Erlotinib With Concurrent Brain Radiotherapy and Secondary Brain Radiotherapy After Recurrence With Erlotinib in NSCLC Non-increased-intracranial-pressure Symptomatic Brain Metastases

TRACTS
Start date: November 2012
Phase: Phase 2
Study type: Interventional

This project is aim to explore non-increased-intracranial-pressure symptomatic brain metastases of NSCLC, and if the OS of secondary brain radiotherapy after recurrence with Erlotinib is better than Erlotinib with concurrent brain radiotherapy. Treatment group are treated with Erlotinib until brain tumor progression, then gave brain radiotherapy, and continued to take Erlotinib till extracranial lesions progression. Control group are Erlotinib with concurrent brain radiotherapy, and continued to take Erlotinib after radiotherapy until recurrence or termination for other reasons.

NCT ID: NCT01763203 Completed - Stroke Clinical Trials

The SUCCEED Trial of Secondary Stroke Prevention

SUCCEED
Start date: February 13, 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to test a newly-developed outpatient clinic and community-based care intervention called SUCCEED (Secondary stroke prevention by Uniting Community and Chronic care model teams Early to End Disparities) for improving control of stroke risk factors among stroke patients in the Los Angeles County "safety net", and to measure the costs of running such an intervention, relative to usual care.

NCT ID: NCT01759238 Terminated - Colorectal Cancer Clinical Trials

Chemoradiotherapy for Patients With Oligometastatic Colorectal Cancer

OLGA
Start date: May 2013
Phase: Phase 2
Study type: Interventional

This study tries to evaluate the role of chemoradiation with capecitabine and bevacizumab in oligometastatic patients neither being progressive nor resectable after chemotherapy.

NCT ID: NCT01755624 Active, not recruiting - Clinical trials for 1-5 Brain Metastases From Non-Small Cell Lung Cancer

Effect of TTFields (150kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-5 Brain Metastases Following Optimal Standard Local Treatment (COMET)

Start date: January 2013
Phase: Phase 2
Study type: Interventional

The study is a prospective, randomly controlled phase II trial, designed to test the efficacy, safety and neurocognitive outcomes of a medical device, the NovoTTF-100A, in the treatment of NSCLC patients with controlled systemic disease, following optimal standard local treatment for 1-5 brain metastases (BM). The device is an experimental, portable, battery operated device for chronic administration of alternating electric fields (termed TTFields or TTF) to the region of the malignant tumor, by means of surface, insulated electrode arrays.

NCT ID: NCT01752036 Completed - Clinical trials for Solid Tumor Spine Metastases

Radiotherapy for Solid Tumor Spine Metastases

Start date: May 20, 2013
Phase: Phase 2
Study type: Interventional

Although it is being increasingly used off protocol, there is minimal data regarding the efficacy of stereotactic radiosurgery to the tumor bed following surgical resection of metastatic lesions to the spine. The primary objective of this study is to evaluate radiographic local recurrence in the tumor bed following stereotactic radiosurgery compared to the expected rate following conventional radiation therapy.

NCT ID: NCT01742702 Recruiting - Aortic Stenosis Clinical Trials

HaemoDYNAMICs in Primary and Secondary Hypertension

DYNAMIC
Start date: May 25, 2006
Phase:
Study type: Observational

The primary aim of the present study was to examine the haemodynamic changes in primary hypertension and secondary hypertension (renal diseases, endocrine diseases, obesity-associated hypertension) with a non-invasive haemodynamic measurement protocol utilizing radial pulse wave analysis and whole-body impedance cardiography in both supine position and during head-up tilt. For comparison, haemodynamics of subjects with chronic fatigue syndrome will also be recorded.